Virtu KCG Holdings’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-60,428
| Closed | -$752K | – | 4165 |
|
|
2016
Q4 | $752K | Sell |
60,428
-3,739
| -6% | -$45K | 0.02% | 1029 |
|
|
2016
Q3 | $878K | Sell |
64,167
-85,849
| -57% | -$862K | 0.02% | 818 |
|
|
2016
Q2 | $1.11M | Buy |
150,016
+117,565
| +362% | +$882K | 0.02% | 671 |
|
|
2016
Q1 | $207K | Sell |
32,451
-36,302
| -53% | -$203K | 0.01% | 2073 |
|
|
2015
Q4 | $430K | Sell |
68,753
-46,890
| -41% | -$308K | 0.01% | 1724 |
|
|
2015
Q3 | $675K | Sell |
115,643
-6,118
| -5% | -$47.1K | 0.01% | 1222 |
|
|
2015
Q2 | $1.01M | Buy |
121,761
+33,611
| +38% | +$297K | 0.02% | 838 |
|
|
2015
Q1 | $726K | Buy |
+88,150
| New | +$652K | 0.01% | 1009 |
|
|
2014
Q4 | – | Sell |
-64,282
| Closed | -$347K | – | 4492 |
|
|
2014
Q3 | $347K | Sell |
64,282
-25,451
| -28% | -$149K | 0.01% | 2147 |
|
|
2014
Q2 | $571K | Buy |
89,733
+64,093
| +250% | +$441K | 0.01% | 1804 |
|
|
2014
Q1 | $207K | Buy |
+25,640
| New | +$200K | ﹤0.01% | 2963 |
|
|
2013
Q4 | – | Sell |
-47,204
| Closed | -$868K | – | 4487 |
|
|
2013
Q3 | $868K | Buy |
+47,204
| New | +$917K | 0.01% | 1325 |
|
Other funds holding ARIA
Virtu KCG Holdings's ARIA Position: Q1 2017 in Review
Virtu KCG Holdings sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 60,428 shares — an estimated $752K sold.
Virtu KCG Holdings first reported a position in ARIA in Q3 2013 and held it in 12 quarters. The position peaked at $1.11M in Q2 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Virtu KCG Holdings reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Virtu KCG Holdings sold 60,428 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $752K.
- Virtu KCG Holdings first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 12 quarters.
- Virtu KCG Holdings's Ariad Pharmaceuticals Inc position peaked at $1.11M in Q2 2016.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.